Jubilant Ingrevia Ltd
NSE:JUBLINGREA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
416.15
818.25
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one JUBLINGREA stock under the Base Case scenario is 506.93 INR. Compared to the current market price of 656.6 INR, Jubilant Ingrevia Ltd is Overvalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Jubilant Ingrevia Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for JUBLINGREA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Jubilant Ingrevia Ltd
Balance Sheet Decomposition
Jubilant Ingrevia Ltd
Current Assets | 17.8B |
Cash & Short-Term Investments | 1.2B |
Receivables | 5.8B |
Other Current Assets | 10.9B |
Non-Current Assets | 29.5B |
Long-Term Investments | 304m |
PP&E | 28.5B |
Intangibles | 204.3m |
Other Non-Current Assets | 515.3m |
Current Liabilities | 12.9B |
Accounts Payable | 7.7B |
Short-Term Debt | 3.1B |
Other Current Liabilities | 2.1B |
Non-Current Liabilities | 7.1B |
Long-Term Debt | 4.3B |
Other Non-Current Liabilities | 2.8B |
Earnings Waterfall
Jubilant Ingrevia Ltd
Revenue
|
40.9B
INR
|
Cost of Revenue
|
-24.7B
INR
|
Gross Profit
|
16.2B
INR
|
Operating Expenses
|
-13.5B
INR
|
Operating Income
|
2.7B
INR
|
Other Expenses
|
-972.1m
INR
|
Net Income
|
1.7B
INR
|
Free Cash Flow Analysis
Jubilant Ingrevia Ltd
INR | |
Free Cash Flow | INR |
Jubilant Ingrevia reported sequential growth in Q1 FY '25, driven by improvements in Specialty Chemicals, which saw EBITDA rise by 50% YoY. The overall revenue was INR 1,024 crores, slightly down from INR 1,075 crores YoY, mainly due to a drop in Chemical Intermediates. The company’s net debt stood at INR 677 crores. The nutrition segment improved, with a 165% QoQ EBITDA growth. The firm reaffirmed its goal for 3x revenue and 4x EBITDA in five years, targeting 20%-plus EBITDA margins. They also noted the completion of their new FDA-inspected manufacturing facility with zero observations.
What is Earnings Call?
JUBLINGREA Profitability Score
Profitability Due Diligence
Jubilant Ingrevia Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Jubilant Ingrevia Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
JUBLINGREA Solvency Score
Solvency Due Diligence
Jubilant Ingrevia Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Jubilant Ingrevia Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JUBLINGREA Price Targets Summary
Jubilant Ingrevia Ltd
According to Wall Street analysts, the average 1-year price target for JUBLINGREA is 754.46 INR with a low forecast of 606 INR and a high forecast of 891.45 INR.
Dividends
Current shareholder yield for JUBLINGREA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Jubilant Ingrevia Ltd. manufactures chemical products. The company is headquartered in Noida, Uttar Pradesh. The company went IPO on 2021-03-19. The firm offers a broad portfolio of ingredients that find application in a range of industries. Its business is focused on three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The Speciality Chemicals businesses is organized across four verticals: Speciality Ingredients, Fine Chemicals, Crop Protection Chemicals, and custom development and manufacturing (CDMO). The Nutrition & Health Solutions segment comprises of Nutrition & Health Ingredients, Animal Nutrition & Health Solutions, and Human Nutrition & Health Solutions segments. The Life Science Chemicals is focused on acetyls and alcohol derivatives, which includes products, such as acetic anhydride, ethyl acetate, anhydrous alcohol, acetaldehyde, formaldehyde and propionic anhydride. The firm is focused on serving pharmaceutical, nutrition, agrochemical, consumer and industrial customers.
Contact
IPO
Employees
Officers
The intrinsic value of one JUBLINGREA stock under the Base Case scenario is 506.93 INR.
Compared to the current market price of 656.6 INR, Jubilant Ingrevia Ltd is Overvalued by 23%.